Evidence map›Paper›PMID 18625161›Full record

ReviewCurrent hypertension reports2008

Advances in the understanding of eclampsia.

S Ananth Karumanchi, Marshall D Lindheimer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current hypertension reports, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Therapeutic potential of extracellular vesicles for treating human pregnancy disorders.Extracellular vesicles and circulating nucleic acids · 2025
    Review
  7. Preeclampsia and eclampsia: the conceptual evolution of a syndrome.American journal of obstetrics and gynecology · 2022
    Review
  8. Article
  9. Review
  10. Bronchopulmonary dysplasia: Pathogenesis and treatment.Experimental and therapeutic medicine · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2012
    Article
  16. Article
  17. Review
  18. Antepartum eclampsia <34 weeks case series: advisable to postpone delivery to administer corticosteroids for fetal pulmonary benefit?Journal of perinatology : official journal of the California Perinatal Association · 2011
    Article
  19. Effects of maternal serum on permeability of glomerular endothelial cell membrane.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S Ananth KarumanchiUniversity of Chicago, 5841 South Maryland Avenue, MC 5100, Chicago, IL 60637, USA.
Marshall D Lindheimer
University of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preeclampsia, a serious hypertensive complication of pregnancy characterized by new-onset hypertension and proteinuria after midpregnancy, is a multisystem disorder that often involves the central nervous system. Neurologic signs and symptoms include hyperreflexia, headaches, visual disturbance, seizures, and cerebral hemorrhage. Eclampsia-new-onset seizures in the setting of preeclampsia-usually occurs before or within 48 hours of delivery, but can present as late as 1 month postpartum (late postpartum eclampsia). Magnesium sulfate is the drug of choice to prevent and treat eclampsia, a recommendation validated through large, randomized, and placebo-controlled trials. This review describes the pathogenesis, clinical features, and treatment of eclampsia, focusing on recent observations regarding roles of circulating antiangiogenic factors in the pathogenesis of the neurologic complications of eclampsia.

Indexed as

AnticonvulsantsAntigens, CDBrainBrain EdemaCerebrovascular CirculationEclampsiaEndoglinFemaleHumansMagnesium SulfatePregnancyProtein-Tyrosine KinasesPuerperal DisordersReceptors, Cell SurfaceAnticonvulsantsAntigens, CDEndoglinENG protein, humanMagnesium SulfateProtein-Tyrosine KinasesReceptors, Cell Surface

Identifiers

PMID18625161
OpenAlexW2069330972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.